Ipca Laboratories Ltd. — Major Shareholding Notification 2019

Apr 3, 2019

I"'J

71 ~ /~~

~<dl W~ <e <e 0 I1Ll~ <e$'(t fro'i) <eIJir(ts [?' If' U~ Cal'(t <e [L DIro'il D'(t <e <d]

Regd. Office: 203-A, Vastu Prestige, New Link Road, Andheri (West), Mumbai 400 053 Tel.: 022 - 26305150 CIN: U67120MH1981PTC024266

1\ t- I I I I

THRU E-MAIL

1[st] April, 2019

The Secretary BSE Ltd. Phiroze Jeejeebhoy Towers 27[th] Floor, Dalal Street Mumbai 400 023 corp. relations@bseindia.com

Dear Sir,

Re: Declaration under Regulation 30 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Ipca Laboratories limited (Scrip code: BSE: 524494 and NSE: IPCALAB)

Pursuant to Regulation 30(1) and 30(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, we are enclosing herewith our annual disclosure under Regulation 30(3) of the said Regulation in respect of shareholding held in Ipca Laboratories Limited by us as Promoters/PAC for the financial year of the Company ended 31st March, 2019.

Kindly acknowledge the receipt.

Thanking you,

Yours faithfully, For and on behalf of Kaygee Investments Private Limited Paranthapa Investments and Traders Private Limited Mexin Medicaments Private Limited Chandurkar Investments Private Limited Kaygee Laboratories Private Limited Paschim Chemicals Private Limited Makers Laboratories Limited M R Chandurkar & Family Premchand Godha & Family

~On{;-- bo{)L Prashant Godha

Encl: a/a

Cc: 1. The National Stock Exchange of India Ltd. 2. Ipca Laboratories Limited Exchange Plaza, 5[th] Fir, Plot # C/1 48, Kandivli Industrial Estate, G Block, Bandra-KurlaComplex, Kandivli (West), Bandra (E), Mumbai 400 051 Mumbai - 400 067 takeover@nse.co.in harish. kamath@ipca.com

~al W {SJ <e <e 0 Ull ~ <e $i! DiJi) <S [1j) i!$ [?) lr n ~ em i! <s [L D DiJi) Di!<S <dl

Regd. Office: 203-A, Vastu Prestige, New Link Road, Andheri (West), Mumbai 400 053 Tel.: 022 - 26305150 CIN: U67120MH1981PTC024266

FORMAT FOR DISCLOSURES UNDER REGULATION 30(1) AND 30(2) OF SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS1REGULATIONS, 2011

Part - A- Details of Shareholding

FORMAT FOR DISCLOSURES UNDER REGULATION 30(1) AND 30(2) OF SEBI	FORMAT FOR DISCLOSURES UNDER REGULATION 30(1) AND 30(2) OF SEBI
(SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS1REGULATIONS, 2011 Part - A- Details of Shareholding
1. Name of the Target Company	Ipca Laboratories Ltd
TC
() 2. Name(s) of the stock exchange(s) where the shares of the TC are	SSE Ltd.
	The National Stock Exchange of India Ltd.
listed 3.Particulars of the shareholder(s) : a. Name of person(s) together with Person Acting in Concert(PAC) whose total holdings(including that in the form of shares, warrants, convertible securities and any other instruments that would entitle the holder to receive shares in TC) is more than 25% of the voting rights of the TC. Or b. Name(s) of the promoter(s), member of the promoter group and PAC with him.
	Kaygee Investments Pvt. Ltd. Chandurkar Investments Pvt. Ltd. Kaygee Laboratories P. Ltd. Paschim Chemicals P. Ltd. Paranthapa Investments and Traders P. Ltd. Makers Laboratories Ltd M. R. Chandurkar Usha M. Chandurkar
	Sameer M. Chandurkar Premchand Godha
	Usha P. Godha Prashant Godha
	Pranay Godha
	Nirmal Jain
	Shawna Godha
	Mexin Medicaments Private Limited
	Neetu Godha

==> picture [327 x 108] intentionally omitted <==

----- Start of picture text -----

I I .,
~tdlW~<S ~ D rm~<S$irDiTD<e[1j)ir$ ~ l')
L0[fn~CBlir<s rLu DiTDntts<d! !7
,\f-
Regd. Office: 203-A, Vastu Prestige, ~ \
New Link Road, Andheri (West), ~ 1\'-
Mumbai 400 053 II
Tel.: 022 - 26305150
CIN: U67120MH1981PTC024266
----- End of picture text -----

~tdlW~<S ~ Drm~<S$irDiTD<e[1j)ir$ L0[fn~CBlir<s rLuDiTDntts<d! Regd. Office: 203-A, Vastu Prestige, New Link Road, Andheri (West), Mumbai 400 053 Tel.: 022 - 26305150 CIN: U67120MH1981PTC024266 I I ., l') ~ !7,\f- ~ \ ~ 1\'- I I	~tdlW~<S ~ Drm~<S$irDiTD<e[1j)ir$ L0[fn~CBlir<s rLuDiTDntts<d! Regd. Office: 203-A, Vastu Prestige, New Link Road, Andheri (West), Mumbai 400 053 Tel.: 022 - 26305150 CIN: U67120MH1981PTC024266 I I ., l') ~ !7,\f- ~ \ ~ 1\'- I I	~tdlW~<S ~ Drm~<S$irDiTD<e[1j)ir$ L0[fn~CBlir<s rLuDiTDntts<d! Regd. Office: 203-A, Vastu Prestige, New Link Road, Andheri (West), Mumbai 400 053 Tel.: 022 - 26305150 CIN: U67120MH1981PTC024266 I I ., l') ~ !7,\f- ~ \ ~ 1\'- I I	~tdlW~<S ~ Drm~<S$irDiTD<e[1j)ir$ L0[fn~CBlir<s rLuDiTDntts<d! Regd. Office: 203-A, Vastu Prestige, New Link Road, Andheri (West), Mumbai 400 053 Tel.: 022 - 26305150 CIN: U67120MH1981PTC024266 I I ., l') ~ !7,\f- ~ \ ~ 1\'- I I	~tdlW~<S ~ Drm~<S$irDiTD<e[1j)ir$ L0[fn~CBlir<s rLuDiTDntts<d! Regd. Office: 203-A, Vastu Prestige, New Link Road, Andheri (West), Mumbai 400 053 Tel.: 022 - 26305150 CIN: U67120MH1981PTC024266 I I ., l') ~ !7,\f- ~ \ ~ 1\'- I I	~tdlW~<S ~ Drm~<S$irDiTD<e[1j)ir$ L0[fn~CBlir<s rLuDiTDntts<d! Regd. Office: 203-A, Vastu Prestige, New Link Road, Andheri (West), Mumbai 400 053 Tel.: 022 - 26305150 CIN: U67120MH1981PTC024266 I I ., l') ~ !7,\f- ~ \ ~ 1\'- I I	~tdlW~<S ~ Drm~<S$irDiTD<e[1j)ir$ L0[fn~CBlir<s rLuDiTDntts<d! Regd. Office: 203-A, Vastu Prestige, New Link Road, Andheri (West), Mumbai 400 053 Tel.: 022 - 26305150 CIN: U67120MH1981PTC024266 I I ., l') ~ !7,\f- ~ \ ~ 1\'- I I
4.Particulars of the shareholding of person(s) mentioned at (3) above As of March 31, 2019, holding of: a) Shares b) VOORg Rights(otherwise than by Rights) c) VVarrants, d) Convertible Securities e) Any other instrument that would entitle the holder to receive shares in the TC.		Sr. No. 1	Name of the shareholder Kaygee Investments	Number of shares held 27018195	% w. r. t. total shares/voting capital wherever applicable 21.38	% of total diluted shares/voting capital of TC 21.38
		2 3 4 5	Pvt. Ltd. Chandurkar Investments Pvt. Ltd. Kaygee Laboratories P. Ltd. Paschim Chemicals P. Ltd. Paranthapa Investments and	6978005 8321000 5029000 15500	5.52 6.59 3.98 0.01	5.52 6.59 3.98 0.01
		6	Traders P. Ltd. Makers Laboratories	101480	0.08	0.08
			Ltd
		7	M. R. Chandurkar	2151000	1.70	1.70
		8 9	Usha M. Chandurkar Sameer M.	2000000 1000000	1.58 0.79	1.58 0.79
			Chandurkar
		10	Premchand Godha	2681340	2.13	2.13
		11	Usha P. Godha	1209370	0.96	0.96
		12	Prashant Godha	759322	0.60	0.60
		13	Pranay Godha	825495	0.65	0.65
		14	Nirmal Jain	115000	0.09	0.09
		15	Bhawna Godha	2500	0.00	0.00
		16	Mexin Medicaments	7029	0.01	0.01
			Private limited
		17	NetuGodha	2000	000	000
			p.		.	.
			Total	58216236	46.07	46.07

lK\:en W~ (S (S U[TilW <S$fcl1ml lrUWalfcS lLu l1mlufccscdl ~ 17 r I- Regd. Office: 203-A, Vastu Prestige, ~ht. New Link Road, Andheri (West), ~ 1\ Mumbai 400 053 I Tel.: 022 - 26305150 CIN: U67120MH1981PTC024266

Part-B**

Name of the Target Company: Ipca Labora~oriesLimited

Name(s) of the person and Whether the person PAN of the Person and Persons Acting in Concert belongs to Promoter I PACs (PAC) with the person Promoter Group

Kaygee Investments Pvt. Ltd.

Chandurkar Investments Pvt. Ltd.

Kaygee Laboratories P. Ltd.

Paschim Chemicals P. Ltd.

Paranthapa Investments and Traders P. Ltd.

Makers Laboratories Ltd

M. R. Chandurkar

Usha M. Chandurkar

Sameer M. Chandurkar

Premchand Godha

Usha P. Godha

Prashant Godha

Pranay Godha

Nirmal Jain

Bhawna Godha Mexin Medicaments Private Limited

Neetu Godha

Yes AAACK2876M Yes AAACC1989M Yes AAACE1901D

Yes AAACP2270J Yes AAACP2485M

Yes AAACM8382J Yes AABPC3338G Yes AAEPC3927G Yes AABPC4600P Yes AFDPG6492E Yes AEMPG2717G Yes AFFPG4317N Yes AEMPG2714F Yes AACPJ6651N Yes AGXPG0394E Yes AAACM3580G

Yes AABPA4082D

Signature of the Authorized Signatory:

Place: Mumbai Date: 1[51] April, 2019

Note

1. In case of promoter(s) making disclosure under regulation 30(2), no additional disclosure under regulation 30(1) is required.

2. (*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.

3. (**) Part-B shall be disclosed to the Stock Exchanges but shall not be disseminated